Introduction
Surgery in the brainstem can be associated with significant morbidity and mortality. , This is because the brainstem has a high density of eloquent gray and white matter structures, including cranial nerve (CN) nuclei, CN tracts, and craniospinal tracts, among others. , With a better understanding of brainstem anatomy, improved neuroimaging, and advances in surgical techniques and monitoring, surgery within the brainstem can occur with reduced morbidity. , In this chapter, we present a case of dorsal pontine brainstem lesion.
Chief complaint: left facial weakness
History of present illness
A 19-year-old, right-handed woman with no significant past medical history presented with prolonged facial weakness. Six months prior she developed left-sided facial weakness with inability to close her eye. She was treated for Bell palsy with steroids with no improvement after 6 months. Imaging was done and revealed a brain lesion ( Fig. 13.1 ).
Medications : None.
Allergies : No known drug allergies.
Past medical and surgical history : None.
Family history : No history of intracranial malignancies.
Social history : College student. No smoking or alcohol.
Physical examination : Awake, alert, oriented to person, place, and time; Language: intact naming and repetition; CNs II to XII intact except left House-Brackmann 5/6; No drift, moves all extremities with full strength.

Clark C. Chen, MD, PhD, University of Minnesota, Minneapolis, MN, United States | Shlomi Constantini, MD, Danil A. Kozyrev, MD, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel | George I. Jallo, MD, Johns Hopkins All Children’s Hospital, St. Petersburg, FL, United States | Vicent Quilis-Quesada, MD, PhD, University of Valencia, Valencia, Spain | |
---|---|---|---|---|
Preoperative | ||||
Additional tests requested | Spine MRI Neuroophthalmology evaluation ENT evaluation Speech and swallow evaluation Intraoperative MRI | Diffusion MRI Spine MRI | Spine MRI | Spine MRI Lumbar puncture/CSF analysis DTI Echocardiogram |
Surgical approach selected | Midline suboccipital craniotomy with intraoperative MRI | Midline suboccipital craniotomy for open biopsy | Midline suboccipital craniotomy | Midline suboccipital craniotomy |
Anatomic corridor | Telovelar | Target inferior medullary aspect | Left telovelar | Left telovelar |
Goal of surgery | Diagnosis, maximal resection | Diagnosis | Maximal resection without neurological deficit | GTR |
Perioperative | ||||
Positioning | Prone | Prone | Prone | Semisitting |
Surgical equipment | Surgical navigation IOM (MEP, SSEP, BAERs, facial nerve EMG) Intraoperative MRI with 5-ALA | Ultrasound IOM Surgical microscope Electrified ultrasonic aspirator | Surgical navigation IOM (SSEP, MEPs, BAERs, cranial nerve EMG) Ultrasound Surgical microscope Nerve stimulator | IOM (SSEP, MEPs, BAERs, cranial nerve EMG) Surgical microscope Ultrasonic aspirator |
Medications | Steroids Mannitol | Steroids | Steroids | None |
Anatomic considerations | Inion, foramen magnum, C1, torcula, transverse sinus, sulcus arteriosus | Cerebellar tonsils | Cerebellar tonsils, PICA, floor of fourth ventricle | Floor of the fourth ventricle, PICA, dentate nuclei |
Complications feared with approach chosen | Venous sinus and vertebral artery injury, brainstem/spinal cord injury | Injury to cranial nerves VI–VII, paramedian pontine reticular formation | Injury to cranial nerves at fourth ventricular floor, PICA stroke | Venous air embolism |
Intraoperative | ||||
Anesthesia | General | General | General | General |
Skin incision | Midline linear from 1–2 cm above inion to C1 | Midline linear from under inion to C2 | Midline linear from under inion to C2 | Midline from inion to C2 |
Bone opening | Midline occipital bone below transverse sinus, including foramen magnum | Midline occipital bone below transverse sinus, including foramen magnum | Midline occipital bone below transverse sinus, including foramen magnum | Midline occipital bone 1 cm below superior nuchal line, including foramen magnum |
Brain exposure | Cerebellum, tonsils | Cerebellum | Cerebellum, tonsils | Cerebellum, tonsils |
Method of resection | Mark Frazier burr hole, incision with preservation of the pericranium, midline muscle dissection with exposure of C1, midline craniotomy, Y-shaped dural opening, open cerebellomedullary fissure, dissect up to rostral half of fourth ventricle, identify abnormal region and confirm with navigation, establish new baseline IOM, biopsy lesion, repeat IOM, debulk lesion and attempt to identify plane, intraoperative MRI to assess need for further resection, watertight closure with pericranium, bone flap fixation | Midline muscle dissection, stripping muscle from C1 and atlanto-axial membrane, midline craniotomy below transverse sinus, opening of foramen magnum, midline Y-shaped dural opening, separate tonsils to visualize the fourth ventricle, biopsy of exophytic medullary component leaving floor of fourth ventricle intact | Midline muscle dissection, exposing C1 lamina, midline occipital craniectomy below sinus incorporating foramen magnum, midline Y-shaped dural openings, section arachnoid between tonsils, identifying and incising tela choroidea +/– inferior medullary velum on left, ultrasound probe and navigation to confirm lesion location if not readily apparent on fourth ventricular floor, stimulate with nerve stimulator to confirm no facial nerve activity, intralesional debulking with suction, stop if lesion is fibrous or neuromonitoring changes, watertight dural closure with synthetic graft, bone flap fixation | Midline muscle dissection, suboccipital craniotomy, Y-shaped dural openings, cerebellomedullary fissure dissection, left tonsil dissection and left PICA protection, open vallecula to expose fourth ventricle, division of inferior medullary velum and tela choroidea, removal of inferior part of the lesion, expose left MCP and SCP and remove remainder, reconstruct cisterna magna with 9-0 suture, watertight dural closure, bone flap fixation |
Complication avoidance | Frazier burr hole preparation, pericranium for closure, opening foramen magnum, telovelar approach, repeated IOM, intraoperative MRI | Separate muscle from atlanto-occipital membrane, opening foramen magnum, working between cerebellar tonsils, biopsy only exophytic medullary component, leave floor of fourth ventricle intact | Opening foramen magnum, left-sided telovelar opening, ultrasound and navigation to confirm lesion, nerve stimulator to identify safe entry zone, intralesional debulking | IOM, left PICA identification and protection, telovelar tonsillar opening, removal of inferior or exophytic portion first |
Postoperative | ||||
Admission | ICU | ICU | ICU | ICU |
Postoperative complications feared | Facial nerve injury, cerebellar retraction injury, CSF leak | Loss of cough and gag reflexes, posterior fossa syndrome, eye movement issues | Facial nerve weakness, diplopia, dysphagia, aspiration, CSF leak | Cranial neuropathies, motor deficit, respiratory insufficiency |
Follow-up testing | MRI within 48 hours after surgery Swallow evaluation Physical and occupational therapy | MRI within 48 hours after surgery | MRI within 48 hours after surgery Swallow evaluation | MRI within 24 hours after surgery |
Follow-up visits | 2 weeks after surgery Initiation of radiation/chemotherapy pending diagnosis | 14 days after surgery MRI 3 months after surgery | 14–21 days after surgery MRI 3 months after surgery | 14 days after surgery |
Adjuvant therapies recommended | ||||
Diffuse astrocytoma (IDH mutant, retain 1p19q) | STR–chemotherapy, delayed radiation for recurrence GTR–observation | STR–radiation/chemotherapy GTR–observation | STR–observation GTR–observation | STR–radiation/PCV GTR–radiation/PCV |
Oligodendroglioma (IDH mutant, 1p19q LOH) | STR–radiation/PCV GTR–observation | STR–chemotherapy GTR–observation | STR–observation GTR–observation | STR–radiation/PCV GTR–radiation/PCV |
Anaplastic astrocytoma (IDH wild type) | STR–radiation/temozolomide GTR–radiation/temozolomide | STR–radiation +/– chemotherapy GTR–radiation +/– chemotherapy | STR–radiation/temozolomide GTR–radiation/temozolomide | STR–radiation/temozolomide GTR–radiation/temozolomide |

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree


